{
  "version": "1.0",
  "last_updated": "2025-12-17",
  "regimens": [
    {
      "regimen_code": "AC-T",
      "regimen_name": "Doxorubicin + Cyclophosphamide → Taxane",
      "phases": ["AC", "T"],
      "drug_components": [
        {"name": "Doxorubicin", "dose": "60 mg/m²", "route": "IV"},
        {"name": "Cyclophosphamide", "dose": "600 mg/m²", "route": "IV"},
        {"name": "Paclitaxel", "dose": "175 mg/m²", "route": "IV", "phase": "T"}
      ],
      "cycle_length_days": 21,
      "nadir_window": {"start": 7, "end": 12},
      "toxicity_profile": {
        "high_risk": [
          "gastrointestinal",
          "hematological",
          "constitutional",
          "neurological",
          "cardiac"
        ],
        "moderate": [
          "dermatological",
          "musculoskeletal"
        ],
        "low": ["pulmonary"],
        "phase_priorities": {
          "pre_session": ["constitutional", "pain", "neurological", "cardiac"],
          "post_session": ["gastrointestinal", "pain", "constitutional"],
          "recovery": ["gastrointestinal", "constitutional", "pain", "oral", "neurological"],
          "nadir": ["infection_signs", "hematological", "constitutional", "musculoskeletal"],
          "inter_cycle": ["constitutional", "neurological", "dermatological", "pain", "gastrointestinal"]
        },
        "phase_specific": {
          "AC": {
            "high_risk": ["nausea", "vomiting", "neutropenia", "alopecia", "fatigue"],
            "moderate": ["mouth_sores", "diarrhea"]
          },
          "T": {
            "high_risk": ["neuropathy", "myalgia", "neutropenia", "fatigue"],
            "moderate": ["nausea", "diarrhea"]
          }
        }
      },
      "symptom_mapping": [
        {"symptom": "nausea", "peak_days": [1, 3], "priority": "high"},
        {"symptom": "vomiting", "peak_days": [1, 3], "priority": "high"},
        {"symptom": "neutropenia", "peak_days": [7, 12], "priority": "high"},
        {"symptom": "fatigue", "peak_days": [4, 14], "priority": "high"},
        {"symptom": "neuropathy", "peak_days": [7, 21], "priority": "high", "phase": "T"},
        {"symptom": "myalgia", "peak_days": [2, 5], "priority": "high", "phase": "T"},
        {"symptom": "diarrhea", "peak_days": [3, 7], "priority": "moderate"},
        {"symptom": "mouth_sores", "peak_days": [5, 10], "priority": "moderate"}
      ]
    },
    {
      "regimen_code": "TC",
      "regimen_name": "Docetaxel + Cyclophosphamide",
      "drug_components": [
        {"name": "Docetaxel", "dose": "75 mg/m²", "route": "IV"},
        {"name": "Cyclophosphamide", "dose": "600 mg/m²", "route": "IV"}
      ],
      "cycle_length_days": 21,
      "nadir_window": {"start": 7, "end": 12},
      "toxicity_profile": {
        "high_risk": [
          "hematological",
          "musculoskeletal",
          "neurological",
          "constitutional",
          "cardiac"
        ],
        "moderate": [
          "gastrointestinal",
          "dermatological"
        ],
        "low": ["pulmonary"],
        "phase_priorities": {
          "pre_session": ["constitutional", "pain", "neurological", "cardiac"],
          "post_session": ["gastrointestinal", "pain", "constitutional"],
          "recovery": ["gastrointestinal", "constitutional", "pain", "musculoskeletal"],
          "nadir": ["infection_signs", "hematological", "constitutional", "musculoskeletal"],
          "inter_cycle": ["constitutional", "neurological", "musculoskeletal", "pain"]
        }
      },
      "symptom_mapping": [
        {"symptom": "neutropenia", "peak_days": [7, 12], "priority": "high"},
        {"symptom": "myalgia", "peak_days": [2, 5], "priority": "high"},
        {"symptom": "fatigue", "peak_days": [3, 14], "priority": "high"},
        {"symptom": "neuropathy", "peak_days": [7, 21], "priority": "high"},
        {"symptom": "fluid_retention", "peak_days": [10, 21], "priority": "moderate"},
        {"symptom": "nausea", "peak_days": [1, 3], "priority": "moderate"},
        {"symptom": "diarrhea", "peak_days": [3, 7], "priority": "moderate"},
        {"symptom": "swelling", "peak_days": [10, 21], "priority": "moderate"}
      ]
    },
    {
      "regimen_code": "T-DM1",
      "regimen_name": "Trastuzumab Emtansine (Ado-trastuzumab emtansine)",
      "drug_components": [
        {"name": "Trastuzumab Emtansine", "dose": "3.6 mg/kg", "route": "IV"}
      ],
      "cycle_length_days": 21,
      "nadir_window": {"start": 7, "end": 14},
      "toxicity_profile": {
        "high_risk": [
          "hematological",
          "hepatic",
          "constitutional",
          "neurological",
          "cardiac"
        ],
        "moderate": [
          "gastrointestinal",
          "musculoskeletal"
        ],
        "low": ["dermatological"],
        "phase_priorities": {
          "pre_session": ["constitutional", "pain", "cardiac", "hepatic"],
          "post_session": ["gastrointestinal", "constitutional", "hepatic"],
          "recovery": ["constitutional", "gastrointestinal", "hepatic", "pain"],
          "nadir": ["hematological", "constitutional", "hepatic"],
          "inter_cycle": ["constitutional", "neurological", "cardiac", "hepatic", "pain"]
        }
      },
      "symptom_mapping": [
        {"symptom": "thrombocytopenia", "peak_days": [7, 14], "priority": "high"},
        {"symptom": "fatigue", "peak_days": [3, 14], "priority": "high"},
        {"symptom": "epistaxis", "peak_days": [7, 14], "priority": "high"},
        {"symptom": "bruising", "peak_days": [7, 14], "priority": "high"},
        {"symptom": "nausea", "peak_days": [1, 3], "priority": "moderate"},
        {"symptom": "headache", "peak_days": [1, 7], "priority": "moderate"},
        {"symptom": "myalgia", "peak_days": [2, 5], "priority": "moderate"}
      ]
    },
    {
      "regimen_code": "Capecitabine",
      "regimen_name": "Capecitabine (Xeloda)",
      "drug_components": [
        {"name": "Capecitabine", "dose": "1250 mg/m² BID", "route": "PO", "schedule": "14 days on, 7 days off"}
      ],
      "cycle_length_days": 21,
      "nadir_window": {"start": 10, "end": 14},
      "toxicity_profile": {
        "high_risk": [
          "gastrointestinal",
          "dermatological",
          "hematological"
        ],
        "moderate": [
          "constitutional",
          "neurological"
        ],
        "low": ["cardiac"],
        "phase_priorities": {
          "pre_session": ["constitutional", "dermatological", "pain"],
          "post_session": ["gastrointestinal", "constitutional"],
          "recovery": ["gastrointestinal", "dermatological", "constitutional", "oral"],
          "nadir": ["hematological", "constitutional", "dermatological"],
          "inter_cycle": ["dermatological", "gastrointestinal", "constitutional", "pain"]
        }
      },
      "symptom_mapping": [
        {"symptom": "hand_foot_syndrome", "peak_days": [7, 14], "priority": "high"},
        {"symptom": "diarrhea", "peak_days": [5, 14], "priority": "high"},
        {"symptom": "nausea", "peak_days": [3, 10], "priority": "moderate"},
        {"symptom": "fatigue", "peak_days": [7, 14], "priority": "moderate"},
        {"symptom": "mouth_sores", "peak_days": [7, 14], "priority": "moderate"},
        {"symptom": "decreased_appetite", "peak_days": [7, 14], "priority": "moderate"}
      ]
    },
    {
      "regimen_code": "Pembrolizumab",
      "regimen_name": "Pembrolizumab (Keytruda) - Immunotherapy",
      "drug_components": [
        {"name": "Pembrolizumab", "dose": "200 mg", "route": "IV"},
        {"name": "Paclitaxel", "dose": "80 mg/m²", "route": "IV", "optional": true},
        {"name": "Carboplatin", "dose": "AUC 5-6", "route": "IV", "optional": true}
      ],
      "cycle_length_days": 21,
      "nadir_window": {"start": 0, "end": 0},
      "toxicity_profile": {
        "high_risk": [
          "constitutional",
          "gastrointestinal",
          "pulmonary",
          "dermatological",
          "infection_signs"
        ],
        "moderate": [],
        "low": ["hematological"],
        "phase_priorities": {
          "pre_session": ["constitutional", "pulmonary", "dermatological"],
          "post_session": ["gastrointestinal", "constitutional", "dermatological"],
          "recovery": ["gastrointestinal", "constitutional", "dermatological", "pulmonary"],
          "nadir": ["constitutional", "gastrointestinal", "infection_signs"],
          "inter_cycle": ["constitutional", "dermatological", "gastrointestinal", "pulmonary"]
        }
      },
      "symptom_mapping": [
        {"symptom": "rash", "peak_days": [1, 21], "priority": "high"},
        {"symptom": "immune_colitis", "peak_days": [7, 21], "priority": "high"},
        {"symptom": "diarrhea", "peak_days": [7, 21], "priority": "high"},
        {"symptom": "cough", "peak_days": [7, 21], "priority": "moderate"},
        {"symptom": "fatigue", "peak_days": [3, 21], "priority": "moderate"},
        {"symptom": "nausea", "peak_days": [1, 7], "priority": "moderate"}
      ]
    }
  ],
  "notes": "Toxicity profiles based on standard chemotherapy guidelines from BC Cancer and NCCN. Peak days are relative to cycle start (infusion date). High-risk symptoms should be monitored more frequently during their peak windows."
}
